| Designing organometallic compounds for catalysis and therapy AL Noffke, A Habtemariam, AM Pizarro, PJ Sadler Chemical Communications 48 (43), 5219-5246, 2012 | 413 | 2012 |
| Organometallic half-sandwich iridium anticancer complexes Z Liu, A Habtemariam, AM Pizarro, SA Fletcher, A Kisova, O Vrana, ... Journal of medicinal chemistry 54 (8), 3011-3026, 2011 | 357 | 2011 |
| A potent cytotoxic photoactivated platinum complex FS Mackay, JA Woods, P Heringová, J Kašpárková, AM Pizarro, ... Proceedings of the National Academy of Sciences 104 (52), 20743-20748, 2007 | 342 | 2007 |
| The potent oxidant anticancer activity of organoiridium catalysts Z Liu, I Romero‐Canelón, B Qamar, JM Hearn, A Habtemariam, ... Angewandte Chemie International Edition 53 (15), 3941-3946, 2014 | 328 | 2014 |
| Unusual DNA binding modes for metal anticancer complexes AM Pizarro, PJ Sadler Biochimie 91 (10), 1198-1211, 2009 | 290 | 2009 |
| Activation mechanisms for organometallic anticancer complexes in medicinal organometallic chemistry AM Pizarro, A Habtemariam, PJ Sadler Medicinal Organometallic Chemistry, 21-56, 2010 | 249* | 2010 |
| Organometallic Ruthenium and Iridium Transfer‐Hydrogenation Catalysts Using Coenzyme NADH as a Cofactor S Betanzos‐Lara, Z Liu, A Habtemariam, AM Pizarro, B Qamar, PJ Sadler Angewandte Chemie International Edition 51 (16), 3897-3900, 2012 | 186 | 2012 |
| Photoactivatable organometallic pyridyl ruthenium (II) arene complexes S Betanzos-Lara, L Salassa, A Habtemariam, O Novakova, AM Pizarro, ... Organometallics 31 (9), 3466-3479, 2012 | 167 | 2012 |
| Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium (III) complexes Z Liu, L Salassa, A Habtemariam, AM Pizarro, GJ Clarkson, PJ Sadler Inorganic chemistry 50 (12), 5777-5783, 2011 | 160 | 2011 |
| Organometallic iridium (III) cyclopentadienyl anticancer complexes containing C, N-chelating ligands Z Liu, A Habtemariam, AM Pizarro, GJ Clarkson, PJ Sadler Organometallics 30 (17), 4702-4710, 2011 | 146 | 2011 |
| Cytotoxicity, hydrophobicity, uptake, and distribution of osmium (II) anticancer complexes in ovarian cancer cells SH van Rijt, A Mukherjee, AM Pizarro, PJ Sadler Journal of medicinal chemistry 53 (2), 840-849, 2010 | 139 | 2010 |
| Organometallic osmium arene complexes with potent cancer cell cytotoxicity Y Fu, A Habtemariam, AM Pizarro, SH van Rijt, DJ Healey, PA Cooper, ... Journal of medicinal chemistry 53 (22), 8192-8196, 2010 | 133 | 2010 |
| Diazido Mixed‐Amine Platinum (IV) Anticancer Complexes Activatable by Visible‐Light Form Novel DNA Adducts Y Zhao, JA Woods, NJ Farrer, KS Robinson, J Pracharova, J Kasparkova, ... Chemistry–A European Journal 19 (29), 9578-9591, 2013 | 103 | 2013 |
| The contrasting chemical reactivity of potent isoelectronic iminopyridine and azopyridine osmium (II) arene anticancer complexes Y Fu, MJ Romero, A Habtemariam, ME Snowden, L Song, GJ Clarkson, ... Chemical Science 3 (8), 2485-2494, 2012 | 102 | 2012 |
| Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells JM Hearn, I Romero-Canelón, AF Munro, Y Fu, AM Pizarro, MJ Garnett, ... Proceedings of the National Academy of Sciences 112 (29), E3800-E3805, 2015 | 86 | 2015 |
| Thermal selectivity of intermolecular versus intramolecular reactions on surfaces B Cirera, N Giménez-Agulló, J Björk, F Martínez-Peńa, A Martin-Jimenez, ... Nature communications 7, 2016 | 74 | 2016 |
| Bipyrimidine ruthenium (II) arene complexes: structure, reactivity and cytotoxicity S Betanzos-Lara, O Novakova, RJ Deeth, AM Pizarro, GJ Clarkson, ... JBIC Journal of Biological Inorganic Chemistry 17 (7), 1033-1051, 2012 | 73 | 2012 |
| Contrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes I Romero-Canelón, AM Pizarro, A Habtemariam, PJ Sadler Metallomics 4 (12), 1271-1279, 2012 | 69 | 2012 |
| Unambiguous Intracellular Localization and Quantification of a Potent Iridium Anticancer Compound by Correlative 3D Cryo X‐Ray Imaging JJ Conesa, AC Carrasco, V Rodríguez‐Fanjul, Y Yang, JL Carrascosa, ... Angewandte Chemie International Edition 59 (3), 1270-1278, 2020 | 59 | 2020 |
| Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs H Li, TY Lin, SL Van Orden, Y Zhao, MP Barrow, AM Pizarro, Y Qi, ... Analytical chemistry 83 (24), 9507-9515, 2011 | 56 | 2011 |
